Prevalence and prediction of trismus in patients with head and neck cancer: A cross-sectional study

Head Neck. 2019 Jan;41(1):64-71. doi: 10.1002/hed.25369. Epub 2018 Dec 18.

Abstract

Background: Trismus occurs frequently in patients with head and neck cancer. Determining the prevalence and associated factors of trismus would enable prediction of the risk of trismus for future patients.

Methods: Based on maximal mouth opening measurements, we determined the prevalence of trismus in 730 patients with head and neck cancer. Associated factors for trismus were analyzed using univariate analyses and multivariate logistic regression analyses. Based on the regression model, a calculation tool to predict trismus was made.

Results: Prevalence of trismus was 23.6%. Factors associated with trismus were: advanced age; partial or full dentition; tumors located at the maxilla; mandible; cheek; major salivary glands; oropharynx; an unknown primary; a free soft tissue transfer after surgery; reirradiation; and chemotherapy.

Conclusion: About one-fourth of patients with head and neck cancer develop trismus. Based on prevalence and associated factors of trismus, a simple calculation tool predicts the risk of trismus in these patients.

Keywords: head and neck neoplasms; mouth neoplasms; oral; risk factors; surgery; trismus.

MeSH terms

  • Age Factors
  • Antineoplastic Agents / adverse effects
  • Cross-Sectional Studies
  • Dentition
  • Female
  • Head and Neck Neoplasms / complications*
  • Head and Neck Neoplasms / therapy
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Radiotherapy / adverse effects
  • Surgical Flaps
  • Trismus / complications*

Substances

  • Antineoplastic Agents